MicroTech Medical Hangzhou Co Ltd
HKEX:2235
MicroTech Medical Hangzhou Co Ltd
Accounts Receivables
MicroTech Medical Hangzhou Co Ltd
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
MicroTech Medical Hangzhou Co Ltd
HKEX:2235
|
Accounts Receivables
¥73.2m
|
CAGR 3-Years
92%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Accounts Receivables
¥41.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Accounts Receivables
¥1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
5%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Accounts Receivables
¥3.6B
|
CAGR 3-Years
23%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Accounts Receivables
¥1.9B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
9%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Accounts Receivables
¥3.3B
|
CAGR 3-Years
67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
MicroTech Medical Hangzhou Co Ltd
Glance View
MicroTech Medical (Hangzhou) Co., Ltd. engages in the research, development, manufacture, and sale of diabetes management medical devices. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2021-10-19. The firm's products such as applicator insulin pump system (Equil), blood glucose monitoring system and continuous blood glucose monitoring system (AiDEX G7) have been commercialized. The firm's products, such as artificial pancreas, are in the process of research and development. The firm's products are sold to overseas markets such as the United States and the European Union.
See Also
What is MicroTech Medical Hangzhou Co Ltd's Accounts Receivables?
Accounts Receivables
73.2m
CNY
Based on the financial report for Dec 31, 2023, MicroTech Medical Hangzhou Co Ltd's Accounts Receivables amounts to 73.2m CNY.
What is MicroTech Medical Hangzhou Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 3Y
92%
Over the last year, the Accounts Receivables growth was 49%. The average annual Accounts Receivables growth rates for MicroTech Medical Hangzhou Co Ltd have been 92% over the past three years .
You don't have any saved screeners yet